Abstract

EE385 Cost per Outcome Analysis of Osimertinib and Atezolizumab for Adjuvant Non-Small Cell Lung Cancer EGFRm Stage II-IIIA in Two Years from Brazilian Private Health System Perspective

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study
Luciana Bahia ... Camila Pepe Ribeiro De Souza
BMC International Health and Human Rights | VOL. 12
Luciana Bahia, et. al.Luciana Bahia ... Camila Pepe Ribeiro De Souza
18 Jun 2012
Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system.
Sandra Fatima Menosi Gualandro ... Marco Aurélio Salvino
PloS one | VOL. 18
Sandra Fatima Menosi Gualandro, et. al.Sandra Fatima Menosi Gualandro ... Marco Aurélio Salvino
26 Jul 2023
P2.16-14 Survival Rates in Non-Small Cell Lung Cancer Patients in the Brazilian Private Health System: A Cohort Study
E Cerqueira ... R Buzzatti Peixoto
Journal of Thoracic Oncology | VOL. 14
E Cerqueira, et. al.E Cerqueira ... R Buzzatti Peixoto
01 Oct 2019
Austerity threatens universal health coverage in Brazil
Katarzyna Doniec ... Lawrence King
The Lancet | VOL. 388
Katarzyna Doniec, et. al.Katarzyna Doniec ... Lawrence King
01 Aug 2016
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Methods for measuring and valuing informal care: A systematic review and meta-analysis in stroke
Neha Das ... Lan Gao
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Neha Das, et. al.Neha Das ... Lan Gao
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
View more papers